Mesoblast Ltd
MESO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001345099
No open-market purchases or sales by Mesoblast Ltd insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $53.3M in total; no superinvestor holds it.
Other share classesMEOBF
Q3 2024 vs. Q2 2024
How the institutions holding Mesoblast Ltd changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 39 | 2 | 43 | +6 |
| Shares | 1.48M | 71.7K | 1.55M | +132.9K (+9.4%) |
| Value | $10.1M | $488.4K | $12.4M | +$2.81M (+29.2%) |
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Mesoblast Ltd at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 81,479 | $665.7K | 0.00% |
| XY Capital Ltd | 29,850 | $243.9K | 0.13% |
| Two Sigma Investments, LP | 20,351 | $166.3K | 0.00% |
| Creative Planning | 17,956 | $146.7K | 0.00% |
| Geode Capital Management, LLC | 11,025 | $90.1K | 0.00% |
| Cubist Systematic Strategies, LLC | 10,321 | $84.3K | 0.00% |
| Bryn Mawr Trust Co | 858 | $7.01K | 0.00% |
| National Bank of Canada | 525 | $4.29K | 0.00% |
| EverSource Wealth Advisors, LLC | 74 | $605 | 0.00% |
| BNP Paribas Arbitrage, SA | 3 | $25 | 0.00% |
Sold out (4)
Institutions that held Mesoblast Ltd at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Chase Investment Counsel Corp | 59,600 | $405.0K |
| Cantor Fitzgerald, L. P. | 16,195 | $110.3K |
| XTX Topco Ltd | 15,063 | $102.6K |
| Comerica Bank | 993 | $6.76K |
Not filed for Q3 2024 yet (2)
Institutions that held Mesoblast Ltd at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 70,230 | $478.3K |
| Institutional & Family Asset Management, LLC | 1,484 | $10.1K |